Theseus Pharmaceuticals Inc (THRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Operating Expenses | 12,080 | 10,579 | 8,659 | 7,374 | 6,814 |
| Operating Income | -12,080 | -10,579 | -8,659 | -7,374 | -6,814 |
| Other Income | 431 | 82 | 3 | 2 | 7 |
| Pre-tax Income | -11,649 | -10,497 | -8,656 | -7,372 | -6,807 |
| Net Income Continuous | -11,649 | -10,497 | -8,656 | -7,372 | -6,807 |
| Net Income | $-11,649 | $-10,497 | $-8,656 | $-7,372 | $-6,807 |
| EPS Basic Total Ops | -0.30 | -0.27 | 14.04 | -5.16 | -6.82 |
| EPS Basic Continuous Ops | -0.30 | -0.27 | 14.06 | -5.16 | -6.83 |
| EPS Diluted Total Ops | -0.30 | -0.27 | 14.04 | -5.16 | -6.82 |
| EPS Diluted Continuous Ops | -0.30 | -0.27 | 14.06 | -5.16 | -6.83 |
| EPS Diluted Before Non-Recurring Items | -0.30 | -0.27 | -0.24 | N/A | N/A |
| EBITDA(a) | $-12,126 | $-10,576 | $-8,658 | $-7,374 | $-6,814 |